Randomized clinical trial concerning diet for outpatients treated with chemotherapy in Hematology /Clinical Oncology divisio
Phase 3
Suspended
- Conditions
- Malignant lymphoma Multiple myeloma Myelodysplastic syndrome Chronic lymphatic leukemia
- Registration Number
- JPRN-UMIN000020875
- Lead Sponsor
- Komaki City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Suspended
- Sex
- All
- Target Recruitment
- 440
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of infection of Grade 3 or more in the first three cycles
- Secondary Outcome Measures
Name Time Method In the first three cycles,thefollowing are to be evaluated as secondary outcoms:1) the incidence of infection of Grade3 ormore with the obvious focus and with neutropenia, 2)the incidence of infection of Grade3 or more without neutropenia, 3) the incidence of febrile neutropenia of Grade3 or more, 4) the rate of discontinuation of treatment due to infection, 5) the rate of postponement of traetment, 6) the difference in the patients' satisfaction between the two diet groups, and 7) the difference in the nutrition state between the two diet groups.